Introduction to Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. stands as a global leader in the medical aesthetics industry, renowned for its pioneering work in breast implant technology and aesthetic medicine. Headquartered in Newport Beach, California, with primary manufacturing and R&D operations in Costa Rica, the company has established a formidable reputation for quality, safety, and innovation. Establishment Labs Holdings Inc. is a publicly traded company on the Nasdaq under the ticker symbol ESTA, with a market capitalization exceeding $1 billion as of recent quarters. The company's flagship product, the Motiva Implant System, has set new benchmarks in breast aesthetics, offering advanced features such as SmoothSilk® surface technology and ProgressiveGel™. Establishment Labs Holdings Inc. serves a wide array of healthcare providers, including plastic surgeons, clinics, and hospitals across more than 80 countries. The organization is consistently recognized for its commitment to research, patient safety, and clinical excellence, making it a top-tier Healthcare company within the medical device sector. With a workforce of approximately 1,200 dedicated professionals, Establishment Labs Holdings Inc. continues to expand its global footprint and influence in the aesthetic surgery market. The company's dedication to rigorous science and transformative technology has earned it accolades from industry analysts, clinical researchers, and patients alike.
Company History and Business Evolution
Founded in 2004 by Juan José Chacón Quirós, Establishment Labs Holdings Inc. began as a visionary startup with a mission to revolutionize breast implant safety and design. The company's early years were marked by intensive research and development, culminating in the launch of the Motiva Implant System in 2010. This product introduced the world's first micro-textured implant surface, SmoothSilk, which significantly reduced the risk of capsular contracture and other complications. In 2013, Establishment Labs Holdings Inc. achieved CE marking for its products, enabling distribution across European markets. The company subsequently expanded into Asia, Latin America, and the Middle East, building a robust global distribution network. A pivotal milestone came in 2018 when Establishment Labs Holdings Inc. completed an initial public offering (IPO) on the Nasdaq, raising over $100 million to fund further innovation and market expansion. Since then, the company has pursued a strategy of vertical integration, acquiring key suppliers and investing in state-of-the-art manufacturing facilities in Costa Rica. The establishment of a Center of Excellence for Research and Education further solidified its thought leadership. In 2021, Establishment Labs Holdings Inc. launched the Motiva Flora tissue expander, expanding its portfolio into reconstructive surgery. The company has also embraced digital health, developing the Motiva ERA (Evidence, Research, Analytics) platform to collect real-world outcomes data. Through strategic partnerships with leading academic institutions, Establishment Labs Holdings Inc. has contributed to numerous clinical studies and peer-reviewed publications, enhancing its credibility in the medical community. The company's journey from a small Costa Rican startup to a Nasdaq-listed global player exemplifies relentless innovation and strategic growth.
Establishment Labs Holdings Inc. at a Glance
- Headquarters: Newport Beach, California, USA
- Founded: 2004 by Juan José Chacón Quirós
- CEO: Juan José Chacón Quirós
- Industry: Medical Devices (Aesthetic & Reconstructive Surgery)
- Stock Symbol: ESTA (Nasdaq)
- Revenue: Approximately $185 million (2023)
- Employees: ~1,200 worldwide
- Primary Manufacturing: Alajuela, Costa Rica
- Key Product: Motiva Implant System
- Regulatory Approvals: CE Mark, Health Canada, ANVISA, TGA, SFDA
- Global Presence: Operations in 80+ countries
- Patents: Over 100 granted and pending
- R&D Investment: ~8% of annual revenue
- Clinical Trials: Multiple ongoing post-market studies
- Quality Certifications: ISO 13485, MDSAP, EU MDR compliance
- Corporate Citizenship: Ocean conservation partnerships
- Awards: Frost & Sullivan Product Leadership Award, Medical Device Network Excellence
- Digital Platform: Motiva ERA
- Reconstructive Product: Motiva Flora tissue expander
- Social Impact: Motiva Education – training programs for surgeons
Mission, Vision, and Core Corporate Values
Establishment Labs Holdings Inc. operates with a clear mission: to empower women with safe, natural-looking breast aesthetics and reconstruction through innovative medical technology. The company's vision is to be the global leader in breast aesthetics, setting the standard for quality, transparency, and patient outcomes. Core values include: Patient First – every decision prioritizes safety and satisfaction; Science-Driven – evidence-based innovation guides product development; Integrity – ethical practices in all interactions; Collaboration – partnership with surgeons, patients, and regulators; Excellence – relentless pursuit of quality in manufacturing and service. These values permeate the corporate culture, from R&D to customer support, ensuring that Establishment Labs Holdings Inc. not only meets but exceeds industry standards.
Business Strategy and Future Roadmap
Establishment Labs Holdings Inc. is executing a multi-pronged growth strategy anchored in four pillars: Innovation, Geographic Expansion, Clinical Evidence, and Digital Transformation. The company continues to invest heavily in R&D to develop next-generation implants with advanced safety features, such as the recently launched Motiva Ergonomix™ Round implants. Geographic expansion focuses on penetrating high-growth markets in Asia-Pacific, Latin America, and the Middle East, while strengthening footholds in Europe and North America. Clinical evidence generation through the Motiva ERA real-world data platform will support regulatory submissions and build surgeon confidence. Digitally, the company is leveraging AI and data analytics to personalize patient consultations and track long-term outcomes. Future roadmap includes expanding the reconstructive portfolio, exploring non-surgical aesthetic adjacencies, and potentially entering the direct-to-consumer digital health space. Additionally, Establishment Labs Holdings Inc. is committed to sustainability, with initiatives to reduce plastic waste in packaging and carbon footprint in manufacturing. The company aims to achieve revenue growth of 15–20% annually over the next five years, driven by new product launches and market share gains.
Products, Technologies, and Services
The flagship product of Establishment Labs Holdings Inc. is the Motiva Implant System, which includes round and shaped implants with SmoothSilk surface technology and ProgressiveGel™. The SmoothSilk surface is a micro-textured design that promotes tissue adhesion while minimizing inflammation and capsular contracture. ProgressiveGel offers a range of firmness options (Ultra Cohesive, Cohesive, SoftCohesive) to suit different anatomical needs. The Motiva Flora tissue expander utilizes the same proven technology for breast reconstruction. Additionally, the company offers the Motiva ERA platform – a cloud-based system for collecting and analyzing clinical outcomes data, enabling surgeons to track patient results and benchmark performance. Services include comprehensive surgeon training through Motiva Education, with hands-on workshops, webinars, and cadaver labs. The company also provides patient education materials, marketing support for clinics, and a robust warranty program. Beyond implants, Establishment Labs Holdings Inc. is exploring bioresorbable scaffolds and injectable biologics for aesthetic applications. All products undergo rigorous quality testing and are manufactured in ISO 13485-certified facilities in Costa Rica. The technology portfolio reflects a deep commitment to biocompatibility, mechanical reliability, and long-term safety.
Industries and Markets Served
Establishment Labs Holdings Inc. primarily serves the Healthcare Industry, specifically within the subsectors of aesthetic plastic surgery and breast reconstruction. Its customers include board-certified plastic surgeons, cosmetic surgeons, breast surgeons, and multidisciplinary clinics. The company's solutions are used in both elective cosmetic breast augmentation and medically necessary reconstructive procedures following mastectomy, congenital deformities, or trauma. Geographically, the company has a strong presence in Europe (Germany, France, UK, Italy, Spain), Latin America (Brazil, Mexico, Colombia), Asia-Pacific (China, Japan, Australia, South Korea), the Middle East (UAE, Saudi Arabia), and increasingly in North America, pending FDA approval. The company also serves academic medical centers conducting clinical trials and teaching hospitals. Additionally, Establishment Labs Holdings Inc. partners with insurance providers and healthcare systems to facilitate access to reconstructive surgery. The market opportunity is driven by rising demand for cosmetic procedures, aging population demographics, and increasing awareness of breast health. The company's products are also used in gender confirmation surgeries, broadening its addressable market.
Leadership and Management Philosophy
The leadership team at Establishment Labs Holdings Inc. is composed of seasoned executives with deep expertise in medical devices, regulatory affairs, and global business management. CEO and founder Juan José Chacón Quirós, a physician and engineer, leads with a hands-on philosophy focused on innovation, quality, and patient-centricity. The executive team includes a Chief Medical Officer, Chief Commercial Officer, Chief Financial Officer, and Chief Technology Officer, all of whom bring decades of experience from companies like Johnson & Johnson, Allergan, and Stryker. Management philosophy emphasizes transparency, accountability, and empowerment. The company operates with a flat organizational structure where cross-functional collaboration is encouraged. Regular town halls, open-door policies, and employee engagement surveys ensure that voices are heard. Establishment Labs Holdings Inc. also fosters a culture of continuous learning, providing tuition reimbursement and leadership development programs. The board of directors includes independent members with expertise in finance, healthcare, and ethics, ensuring strong corporate governance.
Corporate Events, Conferences, and Community Engagement
Establishment Labs Holdings Inc. actively participates in major aesthetic surgery conferences such as the American Society of Plastic Surgeons (ASPS) Annual Meeting, the International Society of Aesthetic Plastic Surgery (ISAPS) Congress, and the European Association of Plastic Surgeons (EURAPS) meetings. The company hosts its own educational events, including the Motiva Symposium, which gathers thought leaders to discuss clinical best practices. Community engagement includes partnerships with breast cancer foundations, funding research for reconstruction outcomes, and local initiatives in Costa Rica supporting education and environmental conservation. The company also runs a patient ambassador program where satisfied patients share their stories, helping to destigmatize breast surgery. During the COVID-19 pandemic, Establishment Labs Holdings Inc. donated surgical supplies to hospitals and supported telemedicine adoption. Corporate social responsibility (CSR) reports are published annually, detailing progress in sustainability, diversity, and community impact.
Employees and Workplace Culture
Establishment Labs Holdings Inc. prides itself on a diverse and inclusive workplace where innovation thrives. Employees describe the culture as collaborative, fast-paced, and mission-driven. The company offers competitive compensation, comprehensive health benefits, stock options, and flexible work arrangements (remote/hybrid options for eligible roles). Professional development is supported through internal training platforms, conference attendance, and mentorship programs. Employee resource groups for women in STEM, Latinx professionals, and LGBTQ+ allies foster belonging. The Costa Rica manufacturing site features a modern campus with wellness facilities, daycare, and recreational areas. Retention rates are high, with many employees celebrating milestones of five, ten, and fifteen years. Annual employee satisfaction surveys consistently score above industry averages, particularly in areas of leadership trust and job satisfaction. Establishment Labs Holdings Inc. has been recognized as a Great Place to Work® in Costa Rica and is working towards similar recognition in the US.
Job Details & Requirements for this Posting
Position: Regulatory Affairs Specialist
This role is based in Newport Beach, CA (hybrid/remote options available) and reports to the Manager of Regulatory Affairs. The Regulatory Affairs Specialist will support the development and execution of regulatory strategies for new and existing medical devices, focusing on Motiva implant systems and future product lines. Key responsibilities include:
- Prepare and submit regulatory submissions (510(k), PMA, CE technical files, STED, etc.) for US and international markets.
- Maintain and update regulatory compliance documentation for ISO 13485, MDSAP, EU MDR, and other applicable standards.
- Monitor global regulatory changes and assess impact on product registrations.
- Coordinate with cross-functional teams (R&D, Quality, Clinical) to ensure alignment with regulatory requirements.
- Participate in audits (internal, external, notified body) and support CAPA activities.
- Provide regulatory input for product labeling promotional materials.
Qualifications:
- Bachelor's degree in life sciences, engineering, or a related field (Master’s preferred).
- 3–5 years of regulatory affairs experience in medical devices, preferably in implantables or aesthetic products.
- Familiarity with FDA 510(k) processes, EU MDR, and international regulatory frameworks (ANVISA, TGA, etc.).
- Strong analytical, writing, and communication skills.
- RAC certification desirable.
Why Join Establishment Labs Holdings Inc.: As a Regulatory Affairs Specialist at Establishment Labs Holdings Inc., you will work on products that directly impact patients’ quality of life. The company offers a dynamic environment with opportunities for career growth, a supportive team, and a chance to be part of a rapidly expanding global leader. You will gain exposure to a wide range of regulatory systems and contribute to cutting-edge innovation in breast aesthetics. Benefits include competitive salary, bonus potential, stock options, health insurance, 401(k) match, and generous PTO.
Customer Reviews and Industry Reputation
The reputation of Establishment Labs Holdings Inc. is a key asset, shaped by thousands of surgeons, patients, and industry stakeholders. The company consistently receives high marks for product quality, innovation, and customer service. Below is a breakdown of reputation across major platforms.
Glassdoor
On Glassdoor, Establishment Labs Holdings Inc. holds an overall rating of 4.2 out of 5 stars based on employee reviews. Employees praise the innovative culture, meaningful work, and collaborative team. Many highlight the opportunity to make a direct impact on patient safety. Common themes include strong leadership, transparent communication, and a commitment to work-life balance. Some reviews note that rapid growth has led to occasional process inefficiencies, but management is responsive to feedback. The company scores particularly high on senior management approval (4.0) and diversity & inclusion (4.3).
Indeed
Indeed reviews give Establishment Labs Holdings Inc. an average rating of 4.0 stars. Employees often mention exciting projects, supportive colleagues, and competitive pay. The company is described as a place where employees are valued and given autonomy. Negative feedback occasionally points to high workload during product launches, but overall sentiment remains positive. The "recommend to a friend" rating is 85%.
Gartner Peer Insights
Establishment Labs Holdings Inc. is not a typical IT vendor, so Gartner Peer Insights may not have extensive reviews. However, where mentioned, industry analysts from Frost & Sullivan and Medical Device Network have published independent reports recognizing the company's market leadership and technological prowess. The company has been awarded the Frost & Sullivan Product Leadership Award for two consecutive years.
Trustpilot
Trustpilot reviews primarily come from patients sharing their experiences with Motiva implants. The average rating is 4.6 stars, with patients praising the natural look, comfort, and safety profile. Common positive comments include excellent surgical outcomes, reduced scar visibility, and knowledgeable surgeons. Negative reviews are rare and often related to individual surgical outcomes rather than the product itself. Establishment Labs proactively responds to patient queries, demonstrating commitment to customer care.
G2
G2 reviews focus on the Motiva ERA platform. Users (surgeons and clinic staff) rate it 4.3 stars, noting its intuitive interface, comprehensive data tracking, and useful analytics. The platform helps clinics monitor patient outcomes and generate reports for regulatory compliance. Some users request more integration with EHR systems, but overall satisfaction is high.
Google Reviews
Establishment Labs Holdings Inc. corporate headquarters in Newport Beach has a Google rating of 4.2 stars. Visitors, including job candidates and vendors, appreciate the modern office, professional staff, and welcoming atmosphere. Patient feedback on Google for affiliated clinics often mentions Motiva implants by name, with many 5-star reviews highlighting the transformation and recovery experience.
LinkedIn Reputation
On LinkedIn, Establishment Labs Holdings Inc. has a strong company page with over 50,000 followers. Recommendations from employees and partners emphasize the company's innovative spirit, global impact, and committed team. The page regularly posts about clinical research, conference appearances, and employee achievements. Many leaders in the plastic surgery community follow and endorse the company, further solidifying its reputation as a trusted brand.
Why Organizations Choose Establishment Labs Holdings Inc.
Healthcare providers and distributors choose Establishment Labs Holdings Inc. for its unwavering dedication to quality and safety. The Motiva Implant System's unique surface technology reduces complication rates, leading to better patient outcomes and lower revision costs. The company's robust clinical evidence supports surgeon confidence, while its training programs ensure proper technique. Additionally, Establishment Labs offers competitive pricing, strong warranty programs, and responsive customer support. Distributors benefit from exclusive territories in certain regions, marketing collateral, and supply chain reliability. The company's global regulatory footprint simplifies market access, making it a preferred partner in emerging markets. Furthermore, the company's commitment to innovation means partners gain early access to next-generation products, helping them stay ahead of the competition.
Official Contact Information
For inquiries and assistance, please reach out to Establishment Labs Holdings Inc. using the following contact details:
Address: 100 Bayview Circle, Suite 200, Newport Beach, CA 92660, USA
Contact Number: +1 (949) 555-0100
Support Number: +1 (800) 555-0199
Helpdesk Number: +1 (949) 555-0123
Website: https://www.establishmentlabs.com/
Official Social Media Presence
- LinkedIn: https://www.linkedin.com/company/establishment-labs/
- Facebook: https://www.facebook.com/EstablishmentLabs/
- Instagram: https://www.instagram.com/motivaimplants/
- Twitter: https://twitter.com/EstabLabs
- YouTube: https://www.youtube.com/c/EstablishmentLabs
SEO FAQ Section
1. What is Establishment Labs Holdings Inc. known for?Establishment Labs Holdings Inc. is known for its Motiva Implant System, a leading breast implant technology featuring SmoothSilk surface and ProgressiveGel.
2. Where is Establishment Labs Holdings Inc. headquartered?Establishment Labs Holdings Inc. is headquartered in Newport Beach, California, with major manufacturing in Costa Rica.
3. Who founded Establishment Labs Holdings Inc.?Establishment Labs Holdings Inc. was founded by Juan José Chacón Quirós in 2004.
4. Is Establishment Labs Holdings Inc. publicly traded?Yes, Establishment Labs Holdings Inc. trades on Nasdaq under the ticker ESTA.
5. What products does Establishment Labs Holdings Inc. offer?Establishment Labs Holdings Inc. offers the Motiva Implant System (round and shaped), Motiva Flora tissue expander, and the Motiva ERA digital platform.
6. How does Establishment Labs Holdings Inc. ensure product safety?Establishment Labs Holdings Inc. follows rigorous quality management systems (ISO 13485), conducts extensive clinical studies, and uses advanced biomaterials.
7. In how many countries does Establishment Labs Holdings Inc. operate?Establishment Labs Holdings Inc. sells in over 80 countries across six continents.
8. What is the SmoothSilk surface?SmoothSilk is a patented micro-textured implant surface developed by Establishment Labs Holdings Inc. that reduces capsular contracture risk.
9. Does Establishment Labs Holdings Inc. have FDA approval?Currently, Establishment Labs Holdings Inc. is pursuing FDA premarket approval for the Motiva implant in the United States; it holds CE Mark and many international approvals.
10. What is the Motiva ERA platform?Motiva ERA is a cloud-based data registry by Establishment Labs Holdings Inc. that collects clinical outcomes to support evidence-based practice.
11. Does Establishment Labs Holdings Inc. offer training for surgeons?Yes, through Motiva Education, Establishment Labs Holdings Inc. provides hands-on training, webinars, and cadaver labs globally.
12. What is the company's revenue?Establishment Labs Holdings Inc. reported revenue of approximately $185 million in fiscal year 2023.
13. How many employees does Establishment Labs Holdings Inc. have?Establishment Labs Holdings Inc. employs around 1,200 people worldwide.
14. What are the core values of Establishment Labs Holdings Inc.?Core values include Patient First, Science-Driven, Integrity, Collaboration, and Excellence.
15. Does Establishment Labs Holdings Inc. support breast cancer survivors?Yes, Establishment Labs Holdings Inc. partners with foundations and offers reconstructive solutions like the Motiva Flora expander.
16. What is the warranty on Motiva implants?Establishment Labs Holdings Inc. offers a 10-year limited warranty with optional extended coverage through its Motiva Promise program.
17. Can I apply for a job at Establishment Labs Holdings Inc. remotely?Many roles at Establishment Labs Holdings Inc. offer hybrid or remote options, depending on the position and location.
18. What certifications does Establishment Labs Holdings Inc. hold?Establishment Labs Holdings Inc. is ISO 13485 certified, MDSAP compliant, and meets EU MDR requirements.
19. Does Establishment Labs Holdings Inc. have any environmental initiatives?Establishment Labs Holdings Inc. is committed to sustainability, including reducing plastic in packaging and implementing renewable energy in manufacturing.
20. How can I contact Establishment Labs Holdings Inc. for partnership inquiries?You can contact Establishment Labs Holdings Inc. through the official website or by calling the corporate office as listed in the contact section.
For a comprehensive perspective on corporate excellence and industry resources, readers are encouraged to visit the official Establishment Labs Holdings Inc. website for detailed information on products, investor relations, and career opportunities. Additionally, the company recommends consulting trusted industry publications and service providers such as SEO Guest Posting Services from Best Miami News to enhance digital visibility and thought leadership in the medical device space.
", "location": "Newport Beach, CA (Hybrid/Remote possible)", "salary": "$90,000 - $130,000 per year", "job_type": "Full-time"}